Alzheimer’s Drug Slows Mental Decline in Trial–But Is It a Breakthrough?
Researchers are cautiously optimistic following companies’ announcement of positive results for lecanemab
Researchers are cautiously optimistic following companies’ announcement of positive results for lecanemab